The median activation/suppression marker values (including PD-1+, CTLA4+, ICOS+, GITR+, HLA-DR+, and Granzyme B+ TILs) in the primary and metastatic tumors are shown in Table 5. The gene discussed is TNFRSF18; the disease is metastatic neoplasm.